EPA and DHA Market Report and Forecast 2025-2034
Description
The global EPA and DHA market is expected to grow at a CAGR of 8.00% during the forecast period of 2025-2034.
The Health Benefits of EPA and DHA are Augmenting the Growth of the Market
The global market for EPA and DHA is being driven by the rising consumer demand for high-quality supplements owing to busy lifestyles. Omega-3 supplements contain a combination of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which have many health benefits. One of the major factors enhancing the growth of the market is the increasing incidences of cardiovascular diseases due to unhealthy consumption of food, lack of exercise, and perpetually increasing levels of stress.
A combination of EPA and DHA can significantly aid in reducing the risks of adverse heart diseases, including heart attack, stroke, and heart failure. This has been augmenting the growth of the market. Moreover, the market growth can also be associated with the rise in disposable incomes and the subsequent willingness to spend on clean label products for a healthy life. Increasing awareness about the importance of Omega-3 on immunity and cardiovascular health, especially amidst the COVID-19 pandemic, led to an increment in the growth of the market.
EPA and DHA: Market Segmentation
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are a combination of Omega-3 supplements, which are predominantly found in oily fish like salmon, mackerel, and tuna. These supplements are rich in proteins and offer many benefits to human and animal health.
Market Breakup by Type
Based on type, the docosahexaenoic acid (DHA) segment is expected to grow significantly in the coming years. This is attributable to the many health benefits of DHA on infant health and the resultant incorporation of DHA in infant formulae. DHA is a rich source of protein, which is also found in breast milk and has tremendous health benefits on the health of a newborn. Due to the low presence of DHA in mothers owing to working populations, unhealthy lifestyles, and stress, among others, manufacturers of baby food are actively using DHA as a primary ingredient, thereby stimulating the market growth. In addition to this, Omega-3 plays a substantial role in improving memory, controlling ADHD, and providing immunity. As a result of inflating disposable incomes and improving living standards, the willingness to spend on a nutrition-rich diet for infant health is stimulating the market growth.
Apart from this, the potential benefits of DHA on treating type-2 diabetes, dementia, and cardiovascular health amongst adults is also expected to contribute to the growth of the segment. DHA ingredients are also widely used for improving eyesight, preventing eye diseases, and for the treatment and prevention of depression by promoting healthy mood. These factors are hence predicted to bolster the overall growth of the market in the coming years.
Key Industry Players in the Global EPA and DHA Market
The report presents a detailed analysis of the following key players in the global EPA and DHA market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions:
The Health Benefits of EPA and DHA are Augmenting the Growth of the Market
The global market for EPA and DHA is being driven by the rising consumer demand for high-quality supplements owing to busy lifestyles. Omega-3 supplements contain a combination of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which have many health benefits. One of the major factors enhancing the growth of the market is the increasing incidences of cardiovascular diseases due to unhealthy consumption of food, lack of exercise, and perpetually increasing levels of stress.
A combination of EPA and DHA can significantly aid in reducing the risks of adverse heart diseases, including heart attack, stroke, and heart failure. This has been augmenting the growth of the market. Moreover, the market growth can also be associated with the rise in disposable incomes and the subsequent willingness to spend on clean label products for a healthy life. Increasing awareness about the importance of Omega-3 on immunity and cardiovascular health, especially amidst the COVID-19 pandemic, led to an increment in the growth of the market.
EPA and DHA: Market Segmentation
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are a combination of Omega-3 supplements, which are predominantly found in oily fish like salmon, mackerel, and tuna. These supplements are rich in proteins and offer many benefits to human and animal health.
Market Breakup by Type
- Eicosapentaenoic Acid (EPA)
- Docosahexaenoic Acid (DHA)
- Triglycerides
- Ethyl Esters
- Fish Oil
- Algae Oil
- Krill Oil
- Others
- Infant Formulae
- Dietary Supplements
- Fortified Food and Beverages
- Pharmaceuticals
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Based on type, the docosahexaenoic acid (DHA) segment is expected to grow significantly in the coming years. This is attributable to the many health benefits of DHA on infant health and the resultant incorporation of DHA in infant formulae. DHA is a rich source of protein, which is also found in breast milk and has tremendous health benefits on the health of a newborn. Due to the low presence of DHA in mothers owing to working populations, unhealthy lifestyles, and stress, among others, manufacturers of baby food are actively using DHA as a primary ingredient, thereby stimulating the market growth. In addition to this, Omega-3 plays a substantial role in improving memory, controlling ADHD, and providing immunity. As a result of inflating disposable incomes and improving living standards, the willingness to spend on a nutrition-rich diet for infant health is stimulating the market growth.
Apart from this, the potential benefits of DHA on treating type-2 diabetes, dementia, and cardiovascular health amongst adults is also expected to contribute to the growth of the segment. DHA ingredients are also widely used for improving eyesight, preventing eye diseases, and for the treatment and prevention of depression by promoting healthy mood. These factors are hence predicted to bolster the overall growth of the market in the coming years.
Key Industry Players in the Global EPA and DHA Market
The report presents a detailed analysis of the following key players in the global EPA and DHA market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions:
- Koninklijke DSM NV
- Corbion N.V.
- BASF SE
- The Archer Daniels Midland Company
- Croda International Plc
- Others
Table of Contents
171 Pages
- 1 Executive Summary
- 1.1 Market Size 2024-2025
- 1.2 Market Growth 2025(F)-2034(F)
- 1.3 Key Demand Drivers
- 1.4 Key Players and Competitive Structure
- 1.5 Industry Best Practices
- 1.6 Recent Trends and Developments
- 1.7 Industry Outlook
- 2 Market Overview and Stakeholder Insights
- 2.1 Market Trends
- 2.2 Key Verticals
- 2.3 Key Regions
- 2.4 Supplier Power
- 2.5 Buyer Power
- 2.6 Key Market Opportunities and Risks
- 2.7 Key Initiatives by Stakeholders
- 3 Economic Summary
- 3.1 GDP Outlook
- 3.2 GDP Per Capita Growth
- 3.3 Inflation Trends
- 3.4 Democracy Index
- 3.5 Gross Public Debt Ratios
- 3.6 Balance of Payment (BoP) Position
- 3.7 Population Outlook
- 3.8 Urbanisation Trends
- 4 Country Risk Profiles
- 4.1 Country Risk
- 4.2 Business Climate
- 5 Global EPA and DHA Market Analysis
- 5.1 Key Industry Highlights
- 5.2 Global EPA and DHA Historical Market (2018-2024)
- 5.3 Global EPA and DHA Market Forecast (2025-2034)
- 5.4 Global EPA and DHA Market by Type
- 5.4.1 Eicosapentaenoic Acid (EPA)
- 5.4.1.1 Historical Trend (2018-2024)
- 5.4.1.2 Forecast Trend (2025-2034)
- 5.4.2 Docosahexaenoic Acid (DHA)
- 5.4.2.1 Historical Trend (2018-2024)
- 5.4.2.2 Forecast Trend (2025-2034)
- 5.5 Global EPA and DHA Market by Form
- 5.5.1 Triglycerides
- 5.5.1.1 Historical Trend (2018-2024)
- 5.5.1.2 Forecast Trend (2025-2034)
- 5.5.2 Ethyl Esters
- 5.5.2.1 Historical Trend (2018-2024)
- 5.5.2.2 Forecast Trend (2025-2034)
- 5.6 Global EPA and DHA Market by Source
- 5.6.1 Fish Oil
- 5.6.1.1 Historical Trend (2018-2024)
- 5.6.1.2 Forecast Trend (2025-2034)
- 5.6.2 Algae Oil
- 5.6.2.1 Historical Trend (2018-2024)
- 5.6.2.2 Forecast Trend (2025-2034)
- 5.6.3 Krill Oil
- 5.6.3.1 Historical Trend (2018-2024)
- 5.6.3.2 Forecast Trend (2025-2034)
- 5.6.4 Others
- 5.7 Global EPA and DHA Market by Application
- 5.7.1 Infant Formulae
- 5.7.1.1 Historical Trend (2018-2024)
- 5.7.1.2 Forecast Trend (2025-2034)
- 5.7.2 Dietary Supplements
- 5.7.2.1 Historical Trend (2018-2024)
- 5.7.2.2 Forecast Trend (2025-2034)
- 5.7.3 Fortified Food and Beverages
- 5.7.3.1 Historical Trend (2018-2024)
- 5.7.3.2 Forecast Trend (2025-2034)
- 5.7.4 Pharmaceuticals
- 5.7.4.1 Historical Trend (2018-2024)
- 5.7.4.2 Forecast Trend (2025-2034)
- 5.7.5 Others
- 5.8 Global EPA and DHA Market by Region
- 5.8.1 North America
- 5.8.1.1 Historical Trend (2018-2024)
- 5.8.1.2 Forecast Trend (2025-2034)
- 5.8.2 Europe
- 5.8.2.1 Historical Trend (2018-2024)
- 5.8.2.2 Forecast Trend (2025-2034)
- 5.8.3 Asia Pacific
- 5.8.3.1 Historical Trend (2018-2024)
- 5.8.3.2 Forecast Trend (2025-2034)
- 5.8.4 Latin America
- 5.8.4.1 Historical Trend (2018-2024)
- 5.8.4.2 Forecast Trend (2025-2034)
- 5.8.5 Middle East and Africa
- 5.8.5.1 Historical Trend (2018-2024)
- 5.8.5.2 Forecast Trend (2025-2034)
- 6 North America EPA and DHA Market Analysis
- 6.1 United States of America
- 6.1.1 Historical Trend (2018-2024)
- 6.1.2 Forecast Trend (2025-2034)
- 6.2 Canada
- 6.2.1 Historical Trend (2018-2024)
- 6.2.2 Forecast Trend (2025-2034)
- 7 Europe EPA and DHA Market Analysis
- 7.1 United Kingdom
- 7.1.1 Historical Trend (2018-2024)
- 7.1.2 Forecast Trend (2025-2034)
- 7.2 Germany
- 7.2.1 Historical Trend (2018-2024)
- 7.2.2 Forecast Trend (2025-2034)
- 7.3 France
- 7.3.1 Historical Trend (2018-2024)
- 7.3.2 Forecast Trend (2025-2034)
- 7.4 Italy
- 7.4.1 Historical Trend (2018-2024)
- 7.4.2 Forecast Trend (2025-2034)
- 7.5 Others
- 8 Asia Pacific EPA and DHA Market Analysis
- 8.1 China
- 8.1.1 Historical Trend (2018-2024)
- 8.1.2 Forecast Trend (2025-2034)
- 8.2 Japan
- 8.2.1 Historical Trend (2018-2024)
- 8.2.2 Forecast Trend (2025-2034)
- 8.3 India
- 8.3.1 Historical Trend (2018-2024)
- 8.3.2 Forecast Trend (2025-2034)
- 8.4 ASEAN
- 8.4.1 Historical Trend (2018-2024)
- 8.4.2 Forecast Trend (2025-2034)
- 8.5 Australia
- 8.5.1 Historical Trend (2018-2024)
- 8.5.2 Forecast Trend (2025-2034)
- 8.6 Others
- 9 Latin America EPA and DHA Market Analysis
- 9.1 Brazil
- 9.1.1 Historical Trend (2018-2024)
- 9.1.2 Forecast Trend (2025-2034)
- 9.2 Argentina
- 9.2.1 Historical Trend (2018-2024)
- 9.2.2 Forecast Trend (2025-2034)
- 9.3 Mexico
- 9.3.1 Historical Trend (2018-2024)
- 9.3.2 Forecast Trend (2025-2034)
- 9.4 Others
- 10 Middle East and Africa EPA and DHA Market Analysis
- 10.1 Saudi Arabia
- 10.1.1 Historical Trend (2018-2024)
- 10.1.2 Forecast Trend (2025-2034)
- 10.2 United Arab Emirates
- 10.2.1 Historical Trend (2018-2024)
- 10.2.2 Forecast Trend (2025-2034)
- 10.3 Nigeria
- 10.3.1 Historical Trend (2018-2024)
- 10.3.2 Forecast Trend (2025-2034)
- 10.4 South Africa
- 10.4.1 Historical Trend (2018-2024)
- 10.4.2 Forecast Trend (2025-2034)
- 10.5 Others
- 11 Market Dynamics
- 11.1 SWOT Analysis
- 11.1.1 Strengths
- 11.1.2 Weaknesses
- 11.1.3 Opportunities
- 11.1.4 Threats
- 11.2 Porter’s Five Forces Analysis
- 11.2.1 Supplier’s Power
- 11.2.2 Buyer’s Power
- 11.2.3 Threat of New Entrants
- 11.2.4 Degree of Rivalry
- 11.2.5 Threat of Substitutes
- 11.3 Key Indicators for Demand
- 11.4 Key Indicators for Price
- 12 Value Chain Analysis
- 13 Competitive Landscape
- 13.1 Supplier Selection
- 13.2 Key Global Players
- 13.3 Key Regional Players
- 13.4 Key Player Strategies
- 13.5 Company Profiles
- 13.5.1 Koninklijke DSM NV
- 13.5.1.1 Company Overview
- 13.5.1.2 Product Portfolio
- 13.5.1.3 Demographic Reach and Achievements
- 13.5.1.4 Certifications
- 13.5.2 Corbion N.V.
- 13.5.2.1 Company Overview
- 13.5.2.2 Product Portfolio
- 13.5.2.3 Demographic Reach and Achievements
- 13.5.2.4 Certifications
- 13.5.3 BASF SE
- 13.5.3.1 Company Overview
- 13.5.3.2 Product Portfolio
- 13.5.3.3 Demographic Reach and Achievements
- 13.5.3.4 Certifications
- 13.5.4 The Archer Daniels Midland Company
- 13.5.4.1 Company Overview
- 13.5.4.2 Product Portfolio
- 13.5.4.3 Demographic Reach and Achievements
- 13.5.4.4 Certifications
- 13.5.5 Croda International Plc
- 13.5.5.1 Company Overview
- 13.5.5.2 Product Portfolio
- 13.5.5.3 Demographic Reach and Achievements
- 13.5.5.4 Certifications
- 13.5.6 Others
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


